Clinical Trials Directory

Trials / Completed

CompletedNCT04720781

The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole

The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole for 4weeks for Erosive Esophagitis Without Any Appointments

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
300 (actual)
Sponsor
Showa Inan General Hospital · Academic / Other
Sex
All
Age
19 Years – 100 Years
Healthy volunteers
Not accepted

Summary

After vonoprazan (20mg/day) or esomeprazole (20mg/day) for 4weeks is prescribed for patients with erosive esophagitis diagnosed by esophagogastroduodenoscopy, the number of patients who will visit our outpatient clinic again due to some reasons without any appointments is compared with vonoprazan group and esomeprazole.

Detailed description

1. Patients who have erosive esophagitis diagnosed by esophagogastroduodenoscopy is enrolled. 2. Vonoprazan (20mg/day) or esomeprazole (20mg/day) is prescribed for 4weeks the patients randomly without next appointments. 3. Some patients may visit our outpatient clinic again due to some reasons without any appointments. 4. The number of the patients who revisit our outpatient clinic again is compared with vonoprazan group and esomeprazole.

Conditions

Interventions

TypeNameDescription
DRUGVonoprazanVonoprazan (20mg/day) is prescribed for 4 weeks.
DRUGEsomeprazoleesomeprazole (20mg/day)

Timeline

Start date
2021-01-21
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2021-01-22
Last updated
2025-05-18

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT04720781. Inclusion in this directory is not an endorsement.